RxDoctor Payments Data

Joshua Goldberg, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · New York, NYNPI 1750488532

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $44,600 of the $50,542 with a category attached, or 88.2%. 13 manufacturers reported payments, led by Truvic Medical, Inc. at 42.5% of the total. Reporting peaked in 2022 at $26,557 and has fallen 97.9% since, to $569 in 2025.

$50,542in general payments, 2019–2025

Across 80 payments — averaging $631.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Truvic Medical, Inc.$22K
  • Neptune Medical Inc.$18K
  • Inari Medical, Inc.$5K
  • Angiodynamics, Inc.$3K
  • Abbott$799
  • Medtronic$778
  • plus $1K from 7 others
$57,029in research payments, 2019–2025

Across 25 payments — averaging $2281.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Inari Medical, Inc.$57K

What the payments were for

  • Consulting fees$44,60088%
  • Speaking & faculty fees$7501%
  • Travel & lodging$2,1094%
  • Food & beverage$3,0826%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Truvic Medical, Inc.13$21,500
Neptune Medical Inc.1$18,000
Inari Medical, Inc.16$5,322
Angiodynamics, Inc.4$2,800
Abbott17$799
Medtronic(2 entities)2$778
Edwards Lifesciences9$491
Cook Medical LLC4$409
Abiomed8$209
Philips North America LLC1$127
Zimmer Biomet2$68
Pfizer2$26
Irhythm Technologies, Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$50,542 in reported general payments places this provider in the 85th percentile of 383 thoracic surgery (cardiothoracic vascular surgery) providers in New York.

See all thoracic surgery (cardiothoracic vascular surgery) providers in New York →

Medicare billing

Part B allowed, 2024
$188,204
Medicare patients
206
Services billed
352

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →